Dr. Weaver is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Box 2581
Ketchum, ID 83340
Summary
- Charles H. Weaver, MD, is an oncologist, former cancer researcher, and pioneer of Internet-based healthcare education, marketing, and application development. Dr. Weaver trained at the University of Washington, the University of Pennsylvania, National Institutes of Health, and Fred Hutchinson Cancer Research Center. His clinical research interests included stem cell therapy, breast cancer, lymphomas, and medical decision-making. He has authored over 75 articles in major medical journals including the Journal of Clinical Oncology, Blood, Cancer, Bone Marrow Transplantation and the New England Journal of Medicine.
As a pioneer of Internet-based cancer education and content marketing, he has been educating and empowering cancer patients since 1997 when he founded CancerConnect.com, one of the first patient-focused cancer web portals. He also founded and serves as Executive Editor of Women: Total Health & Wellness Magazine, and developed and moderates the social media applications used by Harvard, Memorial Sloan Kettering, Roswell Park, UCSF, Ohio State James Cancer Inst and other leading cancer centers to support and engage cancer patients. Combined programming reaches ~ 1 million cancer patients every month.
Education & Training
- University of Washington School of MedicineFellowship, Oncology/Bmt, 1991 - 1993
- University of Pennsylvania Health SystemResidency, Internal Medicine, 1988 - 1991
- University of Washington School of MedicineClass of 1988
- Clinical Center at the National Institutes of HealthFellowship, Cardiovascular Disease, 1987 - 1987
- University of Puget SoundB.S., 1979 - 1983
Publications & Presentations
PubMed
- 35 citationsHigh-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral ...M Brunvand, William I. Bensinger, E. Soll, C. H. Weaver, S Rowley
Bone Marrow Transplantation. 1996-07-01 - 38 citationsPhase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant diseaseKathy Schiffman, William I. Bensinger, F R Appelbaum, S Rowley, K Lilleby
Bone Marrow Transplantation. 1996-06-01 - 565 citationsFactors that influence collection and engraftment of autologous peripheral-blood stem cells.William I. Bensinger, F R Appelbaum, S Rowley, R Storb, Jean E. Sanders
Journal of Clinical Oncology. 1995-10-01
Authored Content
- Genomic Based TreatmentJanuary 2020
- Importance of a Second OpinionFebruary 2019
Press Mentions
- National Ovarian Cancer Coalition Launches NOCC CancerConnect Community Social Media Network for Women with Ovarian CancerSeptember 26th, 2016
- No More Barriers! Patients Rising Launches Multi-Pronged Program to Overcome Policies and Proposals That Limit Access to Medical TreatmentsJune 2nd, 2016
- Cancer Connect Traffic DoublesJuly 11th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: